19th week of 2013 patent applcation highlights part 47 |
Patent application number | Title | Published |
20130116294 | PESTICIDAL COMPOSITION AND ITS USE - A composition comprising a carboxamide compound represented by following formula (I), wherein R | 2013-05-09 |
20130116295 | ANTIPARASITIC FORMULATIONS - Fipronil formulations and fipronil/S-methoprene co-formulations are provided herein. These formulations optionally contain one or more additional active ingredient(s). The formulations comprise an organic solvent, an alcohol co-solvent, and one or more antioxidants and without any crystallization inhibitor. The formulations provided herein are antiparasitic, and can be used, for example, to combat dog and cat parasites, such as, fleas and ticks. | 2013-05-09 |
20130116296 | PYRAZOLE COMPOUND - The present invention relates to a novel serotonin reuptake inhibitor which also exhibits 5-HT | 2013-05-09 |
20130116297 | NOVEL FUSARISETIN COMPOUNDS, AND USE THEREOF - The present invention relates to novel fusarisetin compounds separated from | 2013-05-09 |
20130116298 | ANTITUMOR AGENT OR POSTOPERATIVE ADJUVANT CHEMOTHERAPEUTIC AGENT FOR HEPATOCELLULAR CARCINOMA TREATMENT - The present invention provides an antitumor agent or postoperative adjuvant chemotherapeutic agent for a hepatocellular carcinoma patient who has been treated by transarterial embolization. An antitumor agent or postoperative adjuvant chemotherapeutic agent comprising TSU-68 or a salt thereof, which can be administered to a hepatocellular carcinoma patient within 2 weeks after transarterial embolization, is provided. | 2013-05-09 |
20130116299 | METHODS AND COMPOSITIONS FOR INCREASING SENSITIVITY TO TYROSINE KINASE INHIBITORS - The present invention relates to a method for sensitizing a disease cell expressing the epidermal growth factor receptor (EGFR) to a tyrosine kinase inhibitor selective or specific for EGFR and/or its signalling pathway, the method comprising contacting the cell with a miR-7 miRNA, a precursor or variant thereof, or a miRNA comprising a seed region comprising the sequence GGAAGA. | 2013-05-09 |
20130116300 | TREATMENT OF MEMBRANE BOUND TRANSCRIPTION FACTOR PEPTIDASE, SITE 1 (MBTPS1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO MBTPS1 - The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of Membrane Bound Transcription Factor Peptidase, site 1 (MBTPS1), in particular, by targeting natural antisense polynucleotides of Membrane Bound Transcription Factor Peptidase, site 1 (MBTP-S1). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of MBTPS1. | 2013-05-09 |
20130116301 | ANTISENSE MODULATION OF GCGR EXPRESSION - Provided herein are methods, compounds, and compositions for reducing expression of GCGR mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate metabolic disease, for example, diabetes, or a symptom thereof. | 2013-05-09 |
20130116302 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CHLAMYDIAL INFECTION - Subject of the present invention is a pharmaceutical composition comprising at least one inhibitor of a microorganism selected from the family Chlamydiaceae. | 2013-05-09 |
20130116303 | Antagonists of miRNA-29 Expression and Their Use in the Prevention and Treatment of Aneurysm - The present invention relates to antagonists of the expression and/or the function of the micro RNA miRNA-29 for use in the prevention and/or treatment of aortic aneurysms. Further disclosed is a method for the identification of miRNA-29 antagonists, a pharmaceutical composition comprising said miRNA-29 antagonists and a method for preventing and treating age-related aortic aneurysm formation in a subject in need of such a treatment. | 2013-05-09 |
20130116304 | TMEM195 ENCODES FOR TETRAHYDROBIOPTERIN-DEPENDENT ALKYLGLYCEROL MONOOXYGENASE ACTIVITY - The present invention relates to the provision of a pharmaceutical composition comprising a nucleic acid molecule encoding a alkylglycerol monooxygenase (TMEM195; glyceryl ether monooxygenase; EC 1.14.16.5). The present invention also provides for a method for producing said alkylglycerol monooxygenase (TMEM195; glyceryl ether monooxygenase; EC 1.14.16.5) polypeptides encoded by said polynucleotides. Moreover, the use of such polypeptides as well as of antagonists/inhibitors of such polypeptides in a medical setting (e.g. in from of a pharmaceutical composition) and methods for assessing the activity of a candidate molecule suspected of being an antagonist/inhibitor or agonist/activator in order to identify potential antagonists/inhibitors or agonists/activators of the polypeptide are also provided in the present invention. Finally, the present invention provides kits for carrying out said methods wherein the kits comprise polynucleotides and/or antibodies capable of detecting the activity of alkylglycerol monooxygenase. | 2013-05-09 |
20130116305 | METHODS AND COMPOSITIONS FOR THE INHIBITION OF HIV-1 REPLICATION - This invention relates to methods and compositions for the attenuation of HIV-1 replication in human cells, and especially in human macrophages. The invention particularly concerns the use of inhibitors of P21 (CDKNIA) expression to attenuate such replication. The invention particularly concerns the use of antisense P21 oligonucleotides, siRNA and/or 2-cyano-3,12-dioxooleana-1,9-dien28-oic (CDDO) to attenuate such replication. | 2013-05-09 |
20130116306 | SYSTEM FOR DELIVERING NUCLEIC ACIDS FOR SUPPRESSING TARGET GENE EXPRESSION BY UTILIZING ENDOGENOUS CHYLOMICRON - The object of present invention is to provide a system that can deliver in vivo nucleic acids such as an siRNA for suppressing a target gene expression in vivo more safely and efficiently, and to provide an expression-suppressing agent and a pharmaceutical composition utilizing the system. An introduction substance into chylomiclon, particularly nucleic acids to which an alpha-tocopherol is bound for suppressing a target gene expression, can be delivered more safely and efficiently into hepatic cells in vivo by administering the nucleic aids under the condition where the production of chylomicron is induced in the body. Alternatively, alpha-tocopherol-bound nucleic acids are mixed with extracted chylomiclon, and then they are administered. Consequently, a target gene expression is suppressed, thereby a disease caused by an elevated expression of the target gene can be treated more safely and efficiently. | 2013-05-09 |
20130116307 | NOVEL CYCLIC CATIONIC LIPIDS AND METHODS OF USE - The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel cationic lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic acids and efficient delivery of the encapsulated nucleic acid to cells in vivo. The compositions of the present invention are highly potent, thereby allowing effective knock-down of a specific target protein at relatively low doses. In addition, the compositions and methods of the present invention are less toxic and provide a greater therapeutic index compared to compositions and methods previously known in the art. | 2013-05-09 |
20130116308 | CD36 INHIBITION TO CONTROL OBESITY AND INSULIN SENSITIVITY - The disclosure relates to the therapeutic utility of CD36 antagonists to reduce body weight, inhibit fat accumulation and especially visceral fat accumulation, improve insulin sensitivity, lower blood glucose levels, and treat and prevent metabolic syndrome, pre-diabetes and diabetes, and lower plasma cholesterol levels and decrease fat deposit in the liver. CD36 antagonists, including SAB or its metabolites, such as RA and DSS, are useful for these purposes. | 2013-05-09 |
20130116309 | OLIGOMERIC COMPOUNDS FOR THE MODULATION OF HIF-1A EXPRESSION - Oligonucleotides directed against the hypoxia-inducible factor-1α (HIF-1α) gene are provided for modulating the expression of HIF-1α. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the HIF-1α. Methods of using these compounds for modulation of HIF-1α expression and for the treatment of diseases associated with the hypoxia-inducible factor-1α are provided. Examples of diseases are cancer and pre-eclampsia. The oligonucleotides may be composed of deoxyribonucleosides, a nucleic acid analogue, or Locked Nucleic Acid (LNA) or a combination thereof. | 2013-05-09 |
20130116310 | ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF - An antisense molecule capable of binding to a selected target site to induce exon skipping in the dystrophin gene, as set forth in SEQ ID NO: 1 to 202. | 2013-05-09 |
20130116311 | CATECHOLAMINE ENZYME FUSIONS - Provided is a construct comprising (i) a nucleotide sequence which encodes tyrosine hydroxylase (TH), (ii) a nucleotide sequence which encodes GTP-cyclohydrolase I (CH1) and (iii) a nucleotide sequence which encodes Aromatic Amino Acid Dopa Decarboxylase (AADC) wherein the nucleotide sequence encoding TH is linked to the nucleotide sequence encoding CH1 such that they encode a fusion protein TH-CH1. Also provided is a construct comprising (i) a nucleotide sequence which encodes tyrosine hydroxylase (TH), (ii) a nucleotide sequence which encodes GTP-cyclohydrolase I (CH1) and (iii) a nucleotide sequence which encodes Aromatic Amino Acid Dopa Decarboxylase (AADC) wherein the nucleotide sequence encoding AADC is linked to the nucleotide sequence encoding TH such that they encode a fusion protein AADC-TH or TH-AADC. Further provided is a viral vector comprising such nucleotide sequences and its use in the treatment and/or prevention of Parkinson's disease. | 2013-05-09 |
20130116312 | PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES OF THE AGING - Described herein are routes of synthesis and therapeutic uses of 1-alkyl, 2-acyl glycerol derivatives of formula I: which when administered to mammalian biological systems result in increased cellular concentrations of specific sn-2 substituted ethanolamine plasmalogens independent of the ether lipid synthesis capacity of the system. Elevating levels of the specific sn-2 substituted species in this way can cause lowering of membrane cholesterol levels and the lowering of amyloid secretion. These compounds can be used for the treatment or prevention of diseases of aging associated with increased membrane cholesterol, increased amyloid, and decreased plasmalogen levels, such as neurodegeneration (including Alzheimer's disease, Parkinson's disease and age-related macular degeneration), cognitive impairment, dementia, cancer (e.g. prostate, lung, breast, ovarian, and kidney cancers), osteoporosis, bipolar disorder and vascular diseases (such as atherosclerosis, hypercholesterolemia). | 2013-05-09 |
20130116313 | Compositions and Methods for Inhibiting G Protein Signaling - The present invention relates to methods for identifying agents which bind to specific amino acid residues of the protein interaction site of G protein β protein subunit. Compounds identified in accordance with the assay of the invention and methods for using the compound for modulating at least one activity of a G protein are also provided. | 2013-05-09 |
20130116314 | METHOD OF MAINTAINING OR IMPROVING THE SKIN HEALTH OF AN ANIMAL COMPRISING ADMINISTERING AS A DIETARY SUPPLEMENT A COMPOSITION COMPRISING FLAX SEED OIL AND GAMMA LINOLENIC ACID - A phytochemical composition for use as a veterinary dietary supplement comprising alpha linolenic acid (ALA) and up to 10% gamma linolenic acid (GLA). Preferably the ALA source is flax seed oil and GLA is sourced from borage oil. | 2013-05-09 |
20130116315 | COMPOSITION FOR THE PREVENTION OR TREATMENT OF OBESITY, DYSLIPIDAEMIA, FATTY LIVER OR INSULIN RESISTANCE SYNDROME, COMPRISING PIPERONAL AS AN ACTIVE INGREDIENT - Provided is a composition for the prevention or treatment of obesity, dyslipidaemia, fatty liver or insulin resistance syndrome, comprising piperonal as an active ingredient. The composition of the present invention can be used to advantage as a drug or functional food composition which not only exhibits activity in the prevention or treatment of obesity, hyperlipidaemia or fatty liver but which also causes a significant reduction in fasted blood sugar and blood insulin concentration and hence has an effect in improving Type-2 diabetes or insulin resistance and also improves metabolic disorder which is closely associated therewith. | 2013-05-09 |
20130116316 | Solid Pharmaceutical Compositions Containing Benzofuran Derivatives - The present invention relates to a solid pharmaceutical composition for oral administration characterized in that it comprises a benzofuran derivative with antiarrhythmic activity, or one of the pharmaceutically acceptable salts thereof, as an active principle, and a pharmaceutically acceptable nonionic hydrophilic surfactant optionally in combination with one or more pharmaceutical excipients. | 2013-05-09 |
20130116317 | FURANYL COMPOUNDS AND THE USE THEREOF - Provided herein are substituted furanyl compounds of formula (I), pharmaceutical compositions comprising the compounds, methods of their preparation, and methods of their use. The compounds provided herein are useful for the treatment, prevention, and/or amelioration of various disorders, including cancer and proliferative disorders. In one embodiment, the compounds provided herein modulate eIF4E activity. In one embodiment, the compounds provided herein modulate the Hedgehog pathway activity. In one embodiment, the compounds provided herein are used in combination with surgery, radiation therapy, immuno therapy and/or one or more additional anticancer drugs for the treatment, prevention, and/or amelioration of cancer and proliferative disorders. | 2013-05-09 |
20130116318 | Enzyme Inhibitors - Compounds of formula (I) are inhibitors of histone deacetylase activity, and are useful in the treatment of, for example, cancers: | 2013-05-09 |
20130116319 | Agent for Treating Parkinson's Disease - The present invention relates to the use of 3-methyl-6-(1-methylethenyl)cyclohex-3-ene-1,2-diol, its isomers and derivatives, as a compound for Parkinson disease treatment, that can be used in medicine. The compound is highly active, low toxic and can be synthesized from available natural compound α-pinene. | 2013-05-09 |
20130116320 | GASTRIC RETENTIVE GABAPENTIN DOSAGE FORMS AND METHODS FOR USING SAME - Provided is a method of treating a patient suffering from a pain state by administering to the patient a gastric retentive dosage form of gabapentin that is capable of administration in once-daily or twice daily dosing regimens. By reducing the need to administer gabapentin from the thrice-daily administrations characteristic of immediate release gabapentin, the gastric retentive gabapentin dosage forms provided herein have the advantages of improving patient compliance for gabapentin treatment. In addition to the foregoing, the gastric retentive gabapentin dosages forms also exhibit decreased blood plasma concentrations and increased bioavailability throughout the dosing regimen. | 2013-05-09 |
20130116321 | COMPOSITION CONTAINING SERINE AS AN ACTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF FATTY LIVER DISEASES, AND THE USE THEREOF - The present invention is related to a composition comprising a serine as an active ingredient for treating or preventing fatty liver diseases. The inventive compound significantly inhibits the SREBP-1 transcription activity involved in lipid synthesis and reduced the fatty liver formation through various in vitro test and in vivo test therefore it can be useful in the prevention and treatment of the fatty liver diseases as a medicament or health functional food. | 2013-05-09 |
20130116322 | ALKENYL NAPHTHYLACETIC ACIDS - The invention is concerned with the compounds of formula (I): | 2013-05-09 |
20130116323 | METHODS OF IMPROVING OR PRESERVING LUNG FUNCTION IN A PATIENT WITH A PULMONARY DISORDER - The described invention provides methods for improving or preserving lung function in a patient suffering from a pulmonary disorder comprising an inflammatory component by administering to the patient a pharmaceutical composition comprising a therapeutic amount of N-acetylcysteine, a derivative of N-acetylcysteine, or a pharmaceutically acceptable salt of N-acetylcysteine, wherein the therapeutic amount is effective to improve or preserve the lung function in the patient. | 2013-05-09 |
20130116324 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES OR IMMUNE DISEASES CONTAINING RAMALIN - The present invention relates to the novel use (anti-inflammatory activity) of Ramalin isolated from the Antarctic lichen | 2013-05-09 |
20130116325 | COMPOSITIONS AND METHODS FOR TREATING ANHIDROSIS - Provided herein are compositions and methods useful for the treatment of anhidrosis in mammals, for example, horses. | 2013-05-09 |
20130116326 | TREATMENT OF DELAYED CUTANEOUS HYPERSENSITIVITY CONDITIONS WITH S-FARNESYLTHIOSALICYLIC ACID AND ANALOGS THEREOF - Disclosed are methods of treating a mammalian subject afflicted with a delayed cutaneous hypersensitivity condition, comprising administering to the subject a pharmaceutical composition comprising an effective amount of S-farnesylthiosalicylic acid (FTS) or a structural analog thereof, and compositions for use in the methods. | 2013-05-09 |
20130116327 | Burst Drug Release Compositions - A solid dose composition comprising at least one pharmaceutically active ingredient and at least one controlled release agent and method of manufacturing said composition is disclosed. The burst profile of at least one pharmaceutically active ingredient in the composition is regulated by the apparent viscosity of the controlled release agent and wherein at least one pharmaceutically active ingredient is processed by wet granulation. | 2013-05-09 |
20130116328 | Thermogelling Anaesthetic Compositions - The present invention relates to a thermogelling pharmaceutical composition comprising local anaesthetics in base form and which is suitable for topical administration. The compositions further comprise a polyoxyethylene castor oil and one or more surfactants to obtain thermogelling characteristics. | 2013-05-09 |
20130116329 | Treatment for Reducing Inflammation - A method of treating endometriosis in a person by reducing a cytokine MCP-1 related activity level of an endometriosis implant in said person by 50% or more while not affecting a corresponding TNF-α related activity level by more than comprises providing a pharmaceutical composition comprising a local anaesthetic, in particular lidocaine hydrochloride, and a pharmaceutically acceptable carrier, administering the composition intraperitoneally to said person, thereby substantially reducing the recruitment of macrophages by MCP-1 released from the endometriosis implant. Also disclosed is a corresponding pharmaceutical composition. | 2013-05-09 |
20130116330 | COLCHICINE SOLID-STATE FORMS; METHODS OF MAKING; AND METHODS OF USE THEREOF - Disclosed are new colchicine solid-state forms, methods of preparing the solid-state forms, as well as formulations prepared therefrom and uses thereof. | 2013-05-09 |
20130116331 | MEDICAL GEL - This application pertains to antimicrobial medical gel compositions, the compositions comprising: (a) a gelling agent comprising etherified hydroxyethylcellulose; (b) an antimicrobial agent, specifically the quaternary ammonium compound benzalkonium chloride; (c) a solvent, propanediol being preferred; and (d) water. The compositions through their antimicrobial effectiveness address the problem of cross-contamination leading to infection, while meeting the criteria imposed upon medical gels used in ultrasound procedures which criteria include non-reflectiveness and non-refractiveness to ultrasound waves, pseudoplasticity, spreadability, adherence, acidity compatible with skin, minimal aeration, clarity, and resistance to drying. The medical gels function both as a lubricant and a couplant between a transducer and the skin, and find use in dermal ultrasound, physiotherapy, and medical aesthetic procedures. | 2013-05-09 |
20130116332 | FORMULATIONS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USES THEREOF - Provided herein are pharmaceutical compositions comprising transnorsertraline, salts and polymorphic forms of transnorsertraline, methods of making the compositions, and methods for their use for the treatment of CNS diseases, including depression. | 2013-05-09 |
20130116333 | SOLID TAPENTADOL IN NON-CRYSTALLINE FORM - The invention relates to solid tapentadol in non-crystalline form together with a surface stabiliser in the form of a stable intermediate. In the intermediate of the invention, tapentadol is preferably present in amorphous form or in the form of a solid solution. The invention further relates to methods of producing tapentadol in a solid, non-crystalline form and to pharmaceutical formulations containing solid, non-crystalline tapentadol. | 2013-05-09 |
20130116334 | Treatment of Irritable Bowel Syndrome - A method of treating irritable bowel syndrome in a patient in need thereof by administering to said patient a pharmaceutically effective amount of tapentadol. | 2013-05-09 |
20130116335 | METHOD FOR IDENTIFYING THERAPEUTIC AGENTS FOR TREATMENT OF CANCER - The presence of phosphorylated Cdc27 in cancer cells is utilized to identify patients likely to benefit from treatment with a chemotherapeutic agent that binds to, or binds to and crosslinks, phosphorylated Cdc27, e.g., curcumin, or to determine whether patients undergoing such treatment will continue to respond effectively. Candidate compounds are screened for anticancer effect by testing the ability to bind to or crosslink phosphorylated Cdc27. | 2013-05-09 |
20130116336 | TREATMENT OF ATAXIA TELANGIECTASIA - The present invention relates to methods of treating Ataxia-Telangiectasia (A-T) or Ataxia-telangiectasia like disorder (ATLD) with compounds such as tocotrienol quinones and tocotrienol hydroquinones, including alpha-tocotrienol quinone, in order to alleviate symptoms of the disease. | 2013-05-09 |
20130116337 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS MEDIATED BY OXIDATIVE STRESS OR ELECTROPHILIC ENVIRONMENTAL TOXINS - Methods and compositions are disclosed for treating a subject with a disease or tissue injury mediated by cellular oxidative stress or with an environmental toxicity due to an electrophilic toxicant or pollutant, and for providing a nutritional supplement to a subject and for providing a skin treatment for a subject, where the methods comprise administering to the subject a 1,3-dicarbonyl compound. | 2013-05-09 |
20130116338 | NANOMETAL DISPERSION AND METHOD FOR PREPARING THE SAME - A nanometal dispersion and a method for preparing a nanometal dispersion are provided. The method comprises the following steps: providing a first solution containing a metal ion; providing a second solution containing inulin; mixing the first solution and the second solution to provide a third solution; and providing energy to the third solution to conduct a reduction-oxidation reaction to form a nanometal therein. The produced nanometal dispersion comprises inulin and a nanometal with multimorphology. | 2013-05-09 |
20130116339 | Method for Magnetising Natural and Synthetic Aluminosilicates - Procedure for the magnetization of different inorganic surfaces, whether natural or synthetic, such as aluminosilicates, both synthetic and natural (natural zeolites, synthetic zeolites, alumina, allophane, among others) that give magnetic properties to those surfaces. Objectives of the present application are also the above mentioned surfaces, magnetized, and their different uses. | 2013-05-09 |
20130116340 | Cosmetic And Topical Skin Preparation Comprising Higher Alcohol-Modified Silicone - A cosmetic and a topical skin preparation comprising a higher alcohol-modified silicone (A) with the following general formula (1) wherein R | 2013-05-09 |
20130116341 | IN-VIVO GELLING PHARMACEUTICAL PRE-FORMULATION - Provided herein are in vivo gelling pharmaceutical pre-formulations forming biocompatible hydrogel polymers that are polymerized in vivo and kits comprising at least one nucleophilic compound or monomer unit, at least one electrophilic compound or monomer unit, and optionally at least one therapeutic agent. The biocompatible hydrogel polymer is bioabsorbable and releases the therapeutic agent at a target site, avoiding systemic exposure. | 2013-05-09 |
20130116342 | SALT-RESISTANT EMULSIONS - The invention relates to methods of modulating the stability of emulsions, especially the stability of emulsions to flocculation and coalescence. The use of peptide emulsifiers comprising at least one side chain carboxylate group in preparing emulsions that are stable to flocculation or coalescence in the presence of salt is also described. | 2013-05-09 |
20130116343 | Salivary Protein Markers for Detection of Breast Cancer - A method of diagnosing a patient's risk of breast cancer comprises measuring in a saliva sample from the patient a concentration of at least a first protein marker, wherein the first protein marker is either ubiquitin or cytochrome p450, to provide a set of test data comprising a concentration value of each protein marker in the saliva sample. The test values are then compared to a reference panel comprising a Reference Control Value and a Reference Breast Cancer Value, and a diagnosis of either increased or decreased risk of breast cancer is determined for the patient based on a result of that comparison. A test kit for identifying a person at increased risk of breast cancer is also provided. | 2013-05-09 |
20130116344 | NUCLEIC ACIDS AND METHODS FOR DETECTING TURFGRASS PATHOGENIC FUNGI - The present invention relates to the use of at least one nucleic acid comprising or consisting of: | 2013-05-09 |
20130116345 | LOW TEMPERATURE SULFUR TOLERANT TAR REMOVAL WITH CONCOMITANT SYNTHESIS GAS CONDITIONING - A catalyst comprising NiO, a metal mixture comprising at least one of MoO3 or WO3, a mixture comprising at least one of SiO | 2013-05-09 |
20130116346 | CONVERSION OF ORGANOSULFUR COMPOUNDS TO HYDROGEN SULFIDE IN MIXED ALCOHOL SYNTHESIS REACTOR EFFLUENT - Plants and methods are presented in which organosulfur compounds in a mixed alcohol synthesis reactor effluent are converted into hydrogen sulfide (H | 2013-05-09 |
20130116347 | SYSTEMS AND METHODS FOR THE USE OF FISCHER-TROPSCH TAIL GAS IN A GAS TO LIQUID PROCESS - The present disclosure provides a Fischer-Tropsch tail gas recycling system, including: a Fischer-Tropsch reactor providing a source of tail gas; a first preheater for preheating the tail gas to between about 200 and 300 degrees C.; a hydrogenator for hydrogenating the tail gas; an expansion device for reducing the pressure of the tail gas to between about 2.5 and 5 bar; a second preheater for preheating a feed gas comprising the tail gas and steam to between about 500 and 600 degrees C.; and a catalytic reformer for reforming the feed gas in the presence of a catalyst, wherein the catalytic reformer operates at about 2 bar and about 1000 degrees C., for example. Optionally, CO2 and/or natural gas are also added to the tail gas and/or steam to form the feed gas. | 2013-05-09 |
20130116348 | FISCHER-TROPSCH SYNTHESIS PROCESS AND SYSTEM - The present invention relates to a Fischer-Tropsch synthesis process and system. The process comprises: a) introducing a feedstock gas containing CO and H | 2013-05-09 |
20130116349 | TWO STAGE PROCESS FOR THE CONVERSION OF SYNTHESIS GAS USING A COBALT CATALYST IN THE FIRST STAGE AND A SUPPORTED RUTHENIUM CATALYST IN THE SECOND STAGE - A process is described for the conversion of synthesis gas into hydrocarbons including the steps of;
| 2013-05-09 |
20130116350 | PROMOTED IRON CATALYSTS SUPPORTED ON CARBON NANOTUBES FOR FISCHER-TROPSCH SYNTHESIS - The present application includes iron catalysts promoted with Mo, K and optionally Cu on a multi-walled carbon nanotube (MWCNT) support for high molecular weight hydrocarbon synthesis from synthesis gas. | 2013-05-09 |
20130116351 | PROCESS FOR PRODUCING A METHANATION CATALYST AND A PROCESS FOR THE METHANATION OF SYNTHESIS GAS - The present invention relates to a process for producing a catalyst for carrying out methanation reactions. The production of the catalyst is based on contacting of a hydrotalcite-comprising starting material with a fusible metal salt. The compounds brought into contact with one another are intimately mixed, thermally treated so that the metal salt fraction melts and subsequently subjected to a low-temperature calcination step and a high-temperature calcination step. The metal salt melt comprises at least one metal selected from the group consisting of K, La, Fe, Co, Ni, Cu and Ce, preferably Ni. The metal salt melt more preferably comprises/contains nickel nitrate hexahydrate. The hydrotalcite-comprising starting material is preferably hydrotalcite or a hydrotalcite-like compound as starting material, and the hydrotalcite-comprising starting material preferably comprises magnesium and aluminum as metal species. | 2013-05-09 |
20130116352 | Expandable Starch Beads and Method for Preparing the Same - Provided is expandable starch beads including a starch-monomer copolymer and a foaming agent impregnated in the starch-monomer copolymer, in which the starch-monomer copolymer is prepared by bonding at least one monomer selected from the group consisting of styrene, α-methylstyrene, lactide, lactic acid, acrylic acid, methacrylic acid, acrylic ester, methacrylic ester, acrylonitrile, acrylamide, and caprolactone to starch, and the foaming agent includes at least one selected from the group consisting of C | 2013-05-09 |
20130116353 | COMPOSITION FOR POROUS PLASTICS FOR INTAKE HOUSINGS - Disclosed is a porous plastic resin composition including a polypropylene-based resin, a polyamide-based resin, or an alloy resin made by alloying the two resins to each other with a compatibilizer, reinforced with an inorganic filler or a short glass fiber, and further including a porous inorganic filler and a special inorganic low blowing agent. When the disclosed porous plastic resin composition is used to make an intake housing part, it reduces the weight and cost of an automobile intake housing part. | 2013-05-09 |
20130116354 | HIGH PERFORMANCE FOAM AND COMPOSITE FOAM STRUCTURES AND PROCESSES FOR MAKING SAME - Methods are disclosed for making liquid crystalline polymer (LCP) foams and foam structures of various shapes and forms. LCP foams of the invention have a high compression strength suitable for high performance energy-absorption and energy-impact applications and devices. | 2013-05-09 |
20130116355 | METHOD FOR PREPARING MICROPOROUS POLYOLEFIN FILM WITH IMPROVED PRODUCTIVITY AND EASY CONTROL OF PHYSICAL PROPERTIES - Provided is a method of manufacturing a microporous polyolefin film useable as a battery separator, which is easy to control strength, permeability and shrinking properties of the microporous film and embodies excellent quality uniformity and production stability in fabricating the microporous film. | 2013-05-09 |
20130116356 | DURABLE FOAM OF OLEFIN POLYMERS, METHODS OF MAKING FOAM AND ARTICLES PREPARED FROM SAME - Olefin polymer-based, durable, open-cell foam compositions, structures and articles derived from same; methods for preparation of such foams; and use of the dry durable foams in various applications are disclosed. Further described is use of the foams and structures and articles made of same in absorption, filtration, insulation, cushioning and backing applications, and in particular for odor removal, hygiene and medical applications due to, among other properties, good absorption capabilities, softness and/or flexibility of the foams and their recyclable nature. | 2013-05-09 |
20130116357 | POLYURETHANE HAVING LOW VOLUME SHRINKAGE - The invention relates to the use of solvent-free modified polyisocyanate mixtures on the basis of araliphatic diisocyanates for producing light- and weather-resistant polyurethane bodies having light refraction and low dispersion. | 2013-05-09 |
20130116358 | ACRYLATE-BASED UV-CURABLE INK, METHOD AND AN INK BASE FOR PRODUCING SAME - The invention relates to an acrylate-based UV-curable ink, in particular ink jet ink, having a content of pigments, radical photoinitiators, dispersing agent(s)and optionally additional additives, characterized in that said ink contains at least two radical photoinitiators of the Norrish type I and at least one radically curable monomer in the form of a polyfunctional alkoxylated and/or polyalkoxylated acrylate monomer, which comprises one or more diacrylates and/or triacrylates, wherein the mol ratio of all acrylates to all initiators is approximately 5:1 to 19:1. The invention further relates to a method for producing a UV-curable ink, in particular an ink jet ink of the aforementioned type, wherein 1) a ground product or an ink base is produced by grinding one or more radically curable monomers in the form of a polyfunctional alkoxylated and/or polyalkoxylated acryl monomer, which comprise one or more diacrylate(s) and/or triacrylate(s), with one or more pigments and dispersing agents, in particular optionally additionally with synergists, stabilizers and further additives, in a high-performance mill, in particular in a pearl mill, until a constant viscosity and/or constant particle size develops, and 2) the resulting ground product is mixed with further acrylate monomers and the radical photoinitiators in the form of the Norrish type I, and optionally other additives. Said ground product exhibits advantageous physical properties at elevated temperatures and in long-term storage. | 2013-05-09 |
20130116359 | OPAQUE WATERBORNE UV SCRATCH RESISTANT COATINGS - A coating composition includes a UV curable film forming resin; a thixotropic and/or pseudoplastic anti-settling agent selected from at least one of an amine salt of a synthetic wax, a microcrystalline cellulose compound (MCC), a urea urethane, or a urethane enzymatically modified starch; a mar/scratch resistant additive selected from at least one of a mineral abrasive, glass particles, and ceramic particles; and water. | 2013-05-09 |
20130116360 | MIXING OF TELECHELIC RUBBER FORMULATIONS - The present disclosure is directed to methods for preparing rubber compositions where those rubber compositions comprise at least one telechelic polymer and at least one filler. The methods make use of a mixer that includes a mixing chamber and at least one rotor with wings of specified configuration. Use of the disclosed methods yields a rubber composition with improved properties including an improved dispersion index after master batch mixing as compared to the same rubber composition mixed using standard 4 wing mixers. | 2013-05-09 |
20130116361 | COMPOSITE DISPERSION, METHOD OF PRODUCING THE SAME, AND ARTICLES MADE THEREFROM - The instant invention is a composite dispersion, method of producing the same, and articles made therefrom. The composite dispersion according to the instant invention comprises (1) a first seed dispersion comprising (a) a first internal phase; and (b) an external phase, and (2) a second internal phase; wherein the composite dispersion comprises more than 60 percent by the combined weight of the first internal phase and the second internal phase, and the composite dispersion has a viscosity of less than 10,000 cP measured by RV4 spindle at 20 rpm at greater than 60 weight percent total internal phase, and wherein the composite dispersion has a bimodal particle size distribution and a particle size ratio (P2/P1) in the range of 2 to 200. | 2013-05-09 |
20130116362 | INORGANIC-ORGANIC HYBRID MATERIAL, OPTICAL MATERIAL USING THE SAME, AND INORGANIC-ORGANIC COMPOSITE COMPOSITION - The invention relates to an inorganic-organic hybrid material which comprises an inorganic component and an organic component, has a content of the inorganic component of 20-80% by mass, and has a refractive index of 1.60 or higher, wherein, when preparing a strip specimen having a thickness of 1,000 μm, a width of 5 mm and a length of 70 mm by using the inorganic-organic hybrid material and winding the specimen by 180° on a cylindrical metal rod having a diameter of 10 mm at 25° C., the specimen does not crack. | 2013-05-09 |
20130116363 | ARTIFICIAL MARBLE CONTAINING CHIPS OF PLATE-SHAPED WASTE GLASS AND METHOD FOR FABRICATING THE SAME - The present invention relates to artificial marble including chips of plate-shaped waste glass and a method for fabricating the same. The method includes preparing chips of plate-shaped waste glass having a thickness of 0.6 mm or less and a large diameter of 20 mm or less using thin plate glass as a waste product generated in production of an LCD backlight unit, and adding the chips to a base compound including at least one polymer resin and an additive. The prepared artificial marble has an outer appearance similar to that of natural stone, a surface having excellent properties, and optimum characteristics when used as an interior material for floors, walls, kitchens, and the like. | 2013-05-09 |
20130116364 | METHOD FOR PRODUCING AGGLOMERATES HAVING RUBBER AND WAX, AGGLOMERATES PRODUCED ACCORDING TO THE METHOD, AND USE OF THE AGGLOMERATES IN ASPHALT OR BITUMEN MASSES - A method for producing bulk good of agglomerates made of rubber particles and wax. A composition of the agglomerate and the use of the bulk good to produce asphalt or bitumen masses are created in that rubber is activated by swelling and using a swelling agent and a melt made of viscosity-reducing wax and of optional polyoctenamer is added, the activated rubber particles are agglomerated by means of the viscosity-reducing wax and optional adhesion-improving substances. The resulting larger volume leads to a viscosity reduction and the softening leads to a more intimate and more homogeneous wetting with the wax and, in the mixed good to be produced, a viscosity reduction remaining stable in the mixed good for <180 min and an increased stability of the cross-linking of the rubber molecules among each other after the agglomerates have been incorporated are achieved. | 2013-05-09 |
20130116365 | POLYCARBONATE RESIN COMPOSITIONS AND MOLDED ARTICLES - The invention provides polycarbonate resins which are excellent in terms of light resistance, transparency, hue, heat resistance, thermal stability, and mechanical strength. The invention relates to a polycarbonate resin composition containing: a polycarbonate resin at least containing structural units derived from a dihydroxy compound having the portion represented by the following formula (1) as part of the structure thereof; and a bluing agent. The invention further relates to a polycarbonate resin composition including: a polycarbonate resin (A) containing structural units derived from a dihydroxy compound represented by the following formula (2) as part of the structure thereof; and a bluing agent. | 2013-05-09 |
20130116366 | NOVEL NUCLEATING AGENTS FOR POLYOLEFINS BASED ON ACETAL COMPOUNDS - Described herein are novel acetal compounds capable as nucleating agents for polyolefins. The present invention relates to such compounds synthesized by reacting aromatic aldehydes with polyols and further, to the achievement of high crystallization temperatures in polypropylene compositions upon dispersal therein of formulations containing one or more of the said acetal compounds. | 2013-05-09 |
20130116367 | STABILISED POLYCARBONATE COMPOSITIONS WITH BLENDS OF SILICA AND AN INORGANIC ACID - The present invention relates to polycarbonate compositions having improved processing stability, increased heat stability and a good natural colour, and to their preparation and use, wherein the polycarbonate compositions contain an adsorber or absorber and an acid. | 2013-05-09 |
20130116368 | EMULSION OF AN ASSOCIATIVE ACRYLIC POLYMER POLYMERISED IN THE PRESENCE OF POLYGLYCEROLS AND ITS USE AS A THICKENING AGENT IN AN AQUEOUS FORMULATION - Emulsions containing acrylic associative thickening agents which, when polymerized in the presence of particular polyglycerols, have a thickening power which is remarkably stable over time. | 2013-05-09 |
20130116369 | FUSER COATING COMPOSITION AND METHOD OF MANUFACTURE - The present teachings include a coating composition of a powder of fluorine containing particles, aerogel particles and poly(alkylene carbonate). A method of making a fuser member and the fuser member resulting therefrom is also provided. | 2013-05-09 |
20130116370 | OPTICAL FILM AND PROCESS FOR ITS PRODUCTION - To provide an optical film wherein deterioration of a diimonium compound in an adhesive layer is prevented, and a process for its production. An optical film comprising a base film and an adhesive layer which is formed on the base film and has a massive material dispersed in an adhesive, wherein the massive material contains a diimonium compound represented by the following formula (1) and has a melting point of at least 200° C.: | 2013-05-09 |
20130116371 | Thermally Conductive and Flame-Retarded Compositions - A composition of thermally conductive flame-retarded plastic comprises of: (A) 5 wt % to 45 wt % of polyolefines; (B) 3 wt % to 25 wt % of thermoplastic elastomer; (C) 35 wt % to 85 wt % of thermal conductive fillers; (D) 5 wt % to 55 wt % of flame retardant additive free of halogen, phosphorus and nitrogen; and (E) 0.5 wt % to 6 wt % of coupling agents. The composition exhibits high surface impedance and meets at least the UL94 V1 rating. The composition has a thermal conductivity greater than 1.0 Watts/m-K, a heat deflection temperature greater than 105° C. Besides, the composition is easy to mold and can be made by the method of injection, extrusion or thermoforming. | 2013-05-09 |
20130116372 | METHOD FOR PRODUCING DRY GROUND CALCIUM CARBONATE FOR USE IN THERMOSET POLYESTER RESIN SYSTEMS - A dry ground calcium carbonate filler or additive made by dry grinding calcium carbonate in the presence of an organo-amine and then surface treating the ground calcium carbonate with a dispersant and the method of making the same is disclosed. Dry ground calcium carbonate filler or additive made by dry grinding calcium carbonate in the presence of an organo-amine such as triethanolamine and then surface treating the ground calcium carbonate with a dispersant such as sodium polyacrylate when added to a polyester polymer composition yields a lower viscosity of the polymer system than without the addition of triethanolamine followed by surface treating the ground calcium carbonate with a dispersant. | 2013-05-09 |
20130116373 | METHOD TO FORM AN AQUEOUS DISPERSION OF AN IONOMER-POLYOLEFIN BLEND - Disclosed is a method to form an aqueous dispersion comprising a blend composition comprising or consisting essentially of about 75 to about 99.9 weight of an ionomer composition and about 0.1 to about 25 weight % of an ethylene acrylate ester copolymer composition, a grafted polyolefin composition or a combination thereof, the method comprising mixing the solid blend composition with water heated to a temperature from about 80 to about 100° C. | 2013-05-09 |
20130116374 | POLYMERS BASED ON GRAFTED POLYOLEFINS - The present invention relates to a polymer (P1) obtainable by reaction of at least one component a) with at least one component b), wherein
| 2013-05-09 |
20130116375 | COMPOSITION FOR COATING, AND MOLDED PRODUCT USING THE SAME - The present invention provides a resin composition for coating which is capable of exhibiting an excellent balance between coatability, impact resistance, moldability and chemical resistance, and capable of attaining a good coating appearance, for example, even when a large-size molded product is coated. The resin composition for coating according to the present invention comprises 84.9 to 98.9 parts by mass of the below-mentioned rubber-reinforced vinyl-based resin [A], 1 to 8 parts by mass of a polyester resin [B] and 0.1 to 7.1 parts by mass of a copolymer [C] of ethylene, a (meth)acrylic acid ester and carbon monoxide (with the proviso that a total amount of the components [A], [B] and [C] ([A] +[B] +[C]) is 100 parts by mass): [Rubber-reinforced vinyl-based resin [A]] | 2013-05-09 |
20130116376 | RUBBER COMPOSITION COMPRISING A THERMOPLASTIC FILLER AND COMPATIBILIZER - A rubber composition, which can be used for manufacturing tyres, is based on one or more diene elastomers, on one or more reinforcing fillers, and on a crosslinking system. The rubber composition includes particles of one or more thermoplastic materials chosen from thermoplastic materials with melting or softening points varying from 80° C. to 300° C. The rubber composition also includes one or more compatibilizing agents chosen from block copolymers that includes at least one diene elastomer block and at least one thermoplastic block compatible with the one or more thermoplastic materials. | 2013-05-09 |
20130116377 | ASSOCIATIVE ACRYLIC THICKENING AGENT CONTAINING POLYGLYCEROLS AND ITS USE TO INCREASE THE OPEN TIME OF THIN OR THICK FILMS - The present invention relates to new acrylic associative thickening agents which, when polymerized in the presence of particular polyglycerols, ultimately result in an increase of the open time of the paint or of the thick coating in which they are in incorporated. By so doing, painters and applicators will have more time to work the paint layers gradually or to correct imperfections such as paint droplets, and traces of brushes and filling-knives. | 2013-05-09 |
20130116378 | CURABLE COMPOSITION - An object of the present invention is to provide a curable composition which is made mainly of a polymer having one or more reactive silicon groups, has good curability even when filler is used while a non-organotin catalyst is used, and is further high in industrial practicability. The object is solved by a curable composition, comprising, as constituents, a polymer (A) having one or more reactive silicon groups on average per molecule thereof, the reactive silicon group(s) being (each) a group which can be crosslinked by forming a siloxane bond, a Lewis acid and/or derivative thereof (B), an amine compound (C), a compound (D) having a reactive silicon group, and filler (E), and obtained by mixing the constituents with each other. | 2013-05-09 |
20130116379 | BINDER COMBINATIONS FOR STRUCTURAL DRINKING WATER PIPE COATINGS - The present invention relates to coating systems for the production of quick-drying structural coatings based on (cyclo)aliphatic, filler-containing prepolymers and (cyclo)aliphatic polyisocyanates as well as amino-functional polyaspartic acid esters as curing agents. | 2013-05-09 |
20130116380 | COATINGS FOR IMPLANTABLE DEVICES COMPRISING POLY(HYDROXY-ALKANOATES) AND DIACID LINKAGES - Coatings for an implantable medical device and a method of fabricating thereof are disclosed, the coatings including block-polymers comprising at least one poly(hydroxyacid) or poly(hydroxy-alkanoate) block, at least one block of a biologically compatible polymer and at least one type of linking moiety. | 2013-05-09 |
20130116381 | Process For Making Polysiloxane Emulsions - A process is described for making polysiloxane emulsions by emulsion polymerizing a silicon monomer or oligomer under an elevated pressure. The process produces emulsions of a polysiloxane containing a lower amount of octamethylcyclotetrasiloxane (D | 2013-05-09 |
20130116382 | THERMOPLASTIC COMPOSITION, METHOD OF PRODUCING THE SAME, AND ARTICLES MADE THEREFROM - The instant invention provides a thermoplastic composition, method of producing the same, and articles made therefrom. The thermoplastic composition according to present invention comprises the melt blending product of: (a) from 10 to 75 percent by weight of a continuous phase, based on the total weight of the thermoplastic composition, wherein said continuous phase comprises one or more thermoplastic polymers; and (b) from 25 to 90 percent by weight of a dispersed phase comprising one or more core/shell polymer particles, based on the total weight of the thermoplastic composition, wherein said one or more core/shell polymer particles comprise a crosslinked elastomer core and a thermoplastic shell and wherein said core/shell polymer has an average particle size diameter in the range of from 70 to 10,000 nm. | 2013-05-09 |
20130116383 | LIGNIN-DERIVED THERMOPLASTIC CO-POLYMERS AND METHODS OF PREPARATION - The present invention relates to a crosslinked lignin comprising a lignin structure having methylene or ethylene linking groups therein crosslinking between phenyl ring carbon atoms, wherein said crosslinked lignin is crosslinked to an extent that it has a number-average molecular weight of at least 10,000 g/mol, is melt-processible, and has either a glass transition temperature of at least 100° C., or is substantially soluble in a polar organic solvent or aqueous alkaline solution. Thermoplastic copolymers containing the crosslinked lignin are also described. Methods for producing the crosslinked lignin and thermoplastic copolymers are also described. | 2013-05-09 |
20130116384 | INFILTRANT FOR DENTAL APPLICATION - The invention provides an infiltrant for dental application that comprises crosslinking monomers. In accordance with the invention the infiltrant has a penetration coefficient PC>50 cm/s, and comprises 0.05%-20% by weight of acid-group-containing monomers. | 2013-05-09 |
20130116385 | Propylene polymer compositions - A propylene polymer composition comprising:
| 2013-05-09 |
20130116386 | RESINS - The present invention relates to methods for the production of a resin such as a thermosetting resin, particularly a bioresin, components for use in the methods, and products obtained from the methods. In one aspect the method of forming a resin comprising the steps of: (1) providing an aldehyde-cross-linking agent condensate obtained by reacting a volatile aldehyde with a cross-linking agent; (2) providing a non-volatile aldehyde; and (3) combining the aldehyde-cross-linking agent condensate and the non-volatile aldehyde, thereby forming the resin. | 2013-05-09 |
20130116387 | FLUORINATED BLOCK COPOLYESTERS - Disclosed are block copolyesters comprising blocks of fluoroether functionalized aromatic polyester and blocks of unmodified aromatic polyester, the block copolyesters having a blockiness index, B, in the range of 0.25 to 1.0. The block copolymers incorporated into blends with unmodified aromatic polyester impart oil and soil resistance to shaped articles prepared from the blends. | 2013-05-09 |
20130116388 | PROCESS FOR PREPARING FLUORINATED BLOCK COPOLYESTERS - Disclosed is a polycondensation process for preparing block copolyesters comprising blocks of fluoroether functionalized aromatic polyester and blocks of unmodified polyester. According to the process, a non-fluorinated poly(alkylene arylate) first homopolymer and a fluoroether functionalized poly(alkylene arylate) second homopolymer are combined to form a reaction mixture; the reaction mixture is heated to a temperature above the melting temperatures of each said homopolymer to prepare a molten reaction mixture; and the reaction is continued until the desired molecular weight is achieved. The block copolymers incorporated into blends with unmodified aromatic polyester impart oil and soil resistance to shaped articles prepared from the blends. | 2013-05-09 |
20130116389 | POLYMER BLEND COMPRISING FLUORINATED BLOCK COPOLYESTER - Disclosed are polymer blends prepared by melt blending a fluorinated block copolyester with a non-fluorinated polyester wherein the fluorinated block copolyester comprises blocks of fluoroether modified aromatic polyester and blocks of unmodified polyester. Suitable block copolyesters have a blockiness index, B, in the range of 0.25 to 1.0. Shaped articles prepared from the blends exhibit oil and soil resistance with high fluorine efficiency. | 2013-05-09 |
20130116390 | SHAPED ARTICLES COMPRISING FLUORINATED BLOCK COPOLYESTERS - Disclosed are shaped articles fabricated from polymer blends comprising a fluorinated block copolyester and a non-fluorinated polyester wherein the fluorinated block copolyester comprises blocks of fluoroether modified aromatic polyester and blocks of unmodified polyester. Suitable block copolyesters have a blockiness index, B, in the range of 0.25 to 1.0. Shaped articles that can be made from the copolyesters include films, fibers, and molded parts. | 2013-05-09 |
20130116391 | Method and Apparatus for Monitoring and Restoring Electrical Properties of Polymerization Reactor Wall Film - Described herein are methods for monitoring and restoring electrical properties of polymerization reactor wall films. The method may comprise using a reactor wall monitor to monitor and determine an electrical property, such as the bed voltage or breakdown voltage, of the wall film The method may further comprise adding continuity additive to the reactor and/or adjusting the feed rate of continuity additive being added to the reactor in response to the measured electrical property. | 2013-05-09 |
20130116392 | Polyethylene Composition And Method For Obtaining Same - New plastomer material for use in automotive parts such as bumpers is devised here, which is a novel polyethylene produced by a gas phase process. | 2013-05-09 |
20130116393 | CATALYST COMPONENT - The invention refers to a process for preparing a Group 2 metal/transition metal olefin polymerisation catalyst component in particulate form free of conventional phthalate electron donors and the use thereof in a process for polymerising olefins. | 2013-05-09 |